SCYXSCYNEXIS, Inc.

SCYX Stock Price, Valuation & Chart | SCYNEXIS, Inc.

$5.220+0.05 (+0.97%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic SCYX intrinsic value SCYX calculated fair value vs price

Overview Financials Dividends Ratios

SCYX Historical price chart

SCYX Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization32.83M

PE Ratio-1.53

EPS-3.42

Trading Volume39.65K

Today's High/Low5.33/5.13

Dividend Yield0.00

52 Week High/Low10.48/3.53

Shares Outstanding6.29M

SCYX Financial Statement

SCYX Analyst ratings

SCYX Analysis & performance metrics

SCYX Company profile

SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the…

SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of various fungal infections, including recurrent…

SCYX Management team

Name

Position

Daniella Gigante

Vice President of Human Resources & Information Technology

Ivor Macleod CPA, M.B.A.CFO

Chief Financial Officer

Scott Sukenick J.D.

Chief Legal Officer & Corporate Secretary

David Gonzalez Angulo M.D.CEO

Chief Executive Officer, President & Director

Name

Position

Daniella Gigante

Vice President of Human Resources & Information Technology

Ivor Macleod CPA, M.B.A.CFO

Chief Financial Officer

Scott Sukenick J.D.

Chief Legal Officer & Corporate Secretary

David Gonzalez Angulo M.D.CEO

Chief Executive Officer, President & Director

Management Team

Daniella Gigante

Vice President of Human Resources & Information Technology

Ivor Macleod CPA, M.B.A.CFO

Chief Financial Officer

Scott Sukenick J.D.

Chief Legal Officer & Corporate Secretary

David Gonzalez Angulo M.D.CEO

Chief Executive Officer, President & Director

Management

Daniella Gigante

Vice President of Human Resources & Information Technology

Ivor Macleod CPA, M.B.A.CFO

Chief Financial Officer

Scott Sukenick J.D.

Chief Legal Officer & Corporate Secretary

David Gonzalez Angulo M.D.CEO

Chief Executive Officer, President & Director

Total 4 executives

SCYX Frequently asked questions

What is SCYNEXIS, Inc. (SCYX) Stock Price?

Current stock price of SCYNEXIS, Inc. (SCYX) stock is $5.220. The stock price is +0.97% higher in the session. The intraday range can be seen from this page. Volume of SCYNEXIS, Inc. (SCYX) stock is 39.65K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the SCYNEXIS, Inc. (SCYX) stock price going up or down today?

The stock price of SCYNEXIS, Inc. (SCYX) can change with earnings, company news, and overall market sentiment. SCYNEXIS, Inc. operates in the Healthcare / Drug Manufacturers - Specialty & Generic market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the SCYNEXIS, Inc. stock expensive at its current price?

Whether SCYNEXIS, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for SCYX on this page is -1.53. EPS on this page is -3.42. Compare those figures with peers and growth expectations before deciding if the current SCYNEXIS, Inc. price is justified.

How has the stock price of SCYNEXIS, Inc. (SCYX) performed historically?

Historical performance for SCYNEXIS, Inc. (SCYX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how SCYX reacted to past earnings and market events.

Should I buy SCYNEXIS, Inc. (SCYX) stock, at this price?

Buying SCYNEXIS, Inc. (SCYX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.